PTPN1 and cancer: Notably,they havebeen identified as protein tyrosine phosphatase 1B (PTP1B) inhibitors(Figure c), a promisingclass of compounds for Type II diabetes and cancer treatment.−,  Despite the clinical advancement of PTP1B inhibitors such as trodusquemine and ertiprotafib, their development stalled due to limited efficacy (Figure c).